Executive Board

Intro text: 

The Executive Board is BIG's main scientific and decision-making authority. The Board meets several times a year to see that decisions taken by the General Assembly are carried out and to ensure the smooth running of the association. Board members are elected every four years at the General Assembly, which comprises all member groups and serves as highest authority with respect to overall direction of the association.

David Cameron, MD

BIG Chair
Oncologist – United Kingdom

Martine Piccart-Gebhart, MD, PhD

President of BIG against breast cancer 
Oncologist – Belgium

Ander Urruticoechea, MD, PhD

Treasurer
Oncologist – Spain

Read the latest interview

Carlos Barrios, MD

Member of the executive board
Oncologist - Brazil

Read the latest interview

Philippe Bedard, MD

Member of the executive board
Oncologist - Canada

Read the latest interview

Judith Bliss, MSc

Member of the executive board
Biostatistician – United Kingdom

Read the latest interview

Etienne Brain, MD, PhD

Member of the executive board
Oncologist - France

Read the latest interview

Eva Carrasco, MD

Member of the executive board
Oncologist, Spain

Read the latest interview

Boon Chua, MD

Member of the executive board
Radiation oncologist – Australia

Read the latest interview

Marco Colleoni, MD

Member of the executive board
Oncologist – Italy

Read the latest interview

Angelo Di Leo, MD, PhD

Member of the executive board
Oncologist – Italy

Read the latest interview

Barbro Linderholm, MD, PhD

Member of the executive board
Oncologist – Sweden

Read the latest interview

Sibylle Loibl, MD, PhD

Member of the executive board
Gynaecologist – Germany

Read the latest interview

Shinji Ohno, MD, PhD

Member of the executive board
Surgeon – Japan

Read the latest interview

Aleix Prat, MD, PhD

Member of the executive board
Oncologist – Spain

Read the latest interview

Nick Turner, MD, PHD

Member of the executive board
Oncologist - United Kingdom